Clinical trial
Study to Evaluate the Efficacy of Tetracycline in Epidermolysis Bullosa
NCT00336154 · Rambam Health Care Campus, Other · Withdrawn
Key facts
| NCT number | NCT00336154 |
|---|---|
| Title | Study to Evaluate the Efficacy of Tetracycline in Epidermolysis Bullosa |
| Official title | Randomised Double Blind Crossover Placebo Controlled Study to Evaluate the Efficacy of Tetracycline in Epidermolysis Bullosa |
| Lead sponsor | Rambam Health Care Campus, Other |
| Status | Withdrawn |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Epidermolysis Bullosa |
| Intervention type | Drug |
| Interventions | tetracyclin |
| Enrollment | 0 |
| Primary completion | Jun 1, 2006 |
| First posted | Jun 13, 2006 |
| Last update posted | Oct 28, 2020 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: